Arjuna Natural Extracts Ltd has received a US patent (No. 8859020) for its BCM-95, turmeric extract formulation.  The  composition is for the treatment of Alzheimers disease comprising curcuminoid mixture and added essential oil of turmeric.  The patent also covers method of making the composition.

BCM95 has already undergone human clinical trials in patients with Alzheimers disease at Chinese University of Hong Kong under Prof Larry Baum (2008) and found to be highly beneficial in preventing further cognitive decline, disintegrating amyloid beta plaques, which on deposition in the brain is one of the major cause of development of Alzheimers disease, increases the vitamin E levels in the body and enhancing the curcumin levels in blood. BCM95 is also undergoing two other human clinical trials in patients with Alzheimers disease and subjects at risk of developing Alzheimers disease in Australia under the pioneering researcher Prof Ralph Martins.

“The finding will open a new world of hope to the millions battling with Alzheimer’s every day, as they will now have a natural and safe alternative to controlling Alzheimer’s” says Dr. Benny Antony (Inventor of BCM-95), Joint Managing Director- Arjuna Natural Extracts Ltd.

BCM95 has more than 23 peer reviewed publications and 12 granted and 15 ongoing patents in India, US and Japan and patent pending world over. BCM95 is also being studied for various indications including inflammation, arthritis, diabetes, depression, cancer prevention and treatment, adjuant with chemotherapy and cancer radiation, liver and gastro intestinal diseases etc.